Literature DB >> 28818857

Modeling Inborn Errors of Hepatic Metabolism Using Induced Pluripotent Stem Cells.

Behshad Pournasr1, Stephen A Duncan2.   

Abstract

Inborn errors of hepatic metabolism are because of deficiencies commonly within a single enzyme as a consequence of heritable mutations in the genome. Individually such diseases are rare, but collectively they are common. Advances in genome-wide association studies and DNA sequencing have helped researchers identify the underlying genetic basis of such diseases. Unfortunately, cellular and animal models that accurately recapitulate these inborn errors of hepatic metabolism in the laboratory have been lacking. Recently, investigators have exploited molecular techniques to generate induced pluripotent stem cells from patients' somatic cells. Induced pluripotent stem cells can differentiate into a wide variety of cell types, including hepatocytes, thereby offering an innovative approach to unravel the mechanisms underlying inborn errors of hepatic metabolism. Moreover, such cell models could potentially provide a platform for the discovery of therapeutics. In this mini-review, we present a brief overview of the state-of-the-art in using pluripotent stem cells for such studies.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  embryonic stem cells; genome-wide association study; hypercholesterolemia type II; liver; mutation

Mesh:

Year:  2017        PMID: 28818857      PMCID: PMC5824724          DOI: 10.1161/ATVBAHA.117.309199

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  56 in total

Review 1.  Inborn errors of metabolism: the flux from Mendelian to complex diseases.

Authors:  Brendan Lanpher; Nicola Brunetti-Pierri; Brendan Lee
Journal:  Nat Rev Genet       Date:  2006-06       Impact factor: 53.242

Review 2.  Cornerstones of CRISPR-Cas in drug discovery and therapy.

Authors:  Christof Fellmann; Benjamin G Gowen; Pei-Chun Lin; Jennifer A Doudna; Jacob E Corn
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

3.  Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency.

Authors:  Edgar N Tafaleng; Souvik Chakraborty; Bing Han; Pamela Hale; Wanquan Wu; Alejandro Soto-Gutierrez; Carol A Feghali-Bostwick; Andrew A Wilson; Darrell N Kotton; Masaki Nagaya; Stephen C Strom; Jayanta Roy-Chowdhury; Donna B Stolz; David H Perlmutter; Ira J Fox
Journal:  Hepatology       Date:  2015-04-13       Impact factor: 17.425

4.  A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia.

Authors:  Max A Cayo; Sunil K Mallanna; Francesca Di Furio; Ran Jing; Lauren B Tolliver; Matthew Bures; Amanda Urick; Fallon K Noto; Evanthia E Pashos; Matthew D Greseth; Maciej Czarnecki; Paula Traktman; Wenli Yang; Edward E Morrisey; Markus Grompe; Daniel J Rader; Stephen A Duncan
Journal:  Cell Stem Cell       Date:  2017-04-06       Impact factor: 24.633

5.  Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells.

Authors:  Arefeh Ghodsizadeh; Adeleh Taei; Mehdi Totonchi; Ali Seifinejad; Hamid Gourabi; Behshad Pournasr; Nasser Aghdami; Reza Malekzadeh; Navid Almadani; Ghasem Hosseini Salekdeh; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

6.  Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen.

Authors:  Arnaud Carpentier; Ila Nimgaonkar; Virginia Chu; Yuchen Xia; Zongyi Hu; T Jake Liang
Journal:  Stem Cell Res       Date:  2016-03-29       Impact factor: 2.020

7.  Variability in the generation of induced pluripotent stem cells: importance for disease modeling.

Authors:  Alejandra M Vitale; Nicholas A Matigian; Sugandha Ravishankar; Bernadette Bellette; Stephen A Wood; Ernst J Wolvetang; Alan Mackay-Sim
Journal:  Stem Cells Transl Med       Date:  2012-09-07       Impact factor: 6.940

8.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.

Authors:  Kosuke Yusa; S Tamir Rashid; Helene Strick-Marchand; Ignacio Varela; Pei-Qi Liu; David E Paschon; Elena Miranda; Adriana Ordóñez; Nicholas R F Hannan; Foad J Rouhani; Sylvie Darche; Graeme Alexander; Stefan J Marciniak; Noemi Fusaki; Mamoru Hasegawa; Michael C Holmes; James P Di Santo; David A Lomas; Allan Bradley; Ludovic Vallier
Journal:  Nature       Date:  2011-10-12       Impact factor: 49.962

9.  Small-molecule-driven hepatocyte differentiation of human pluripotent stem cells.

Authors:  Richard Siller; Sebastian Greenhough; Elena Naumovska; Gareth J Sullivan
Journal:  Stem Cell Reports       Date:  2015-04-30       Impact factor: 7.765

10.  Mapping the Cell-Surface N-Glycoproteome of Human Hepatocytes Reveals Markers for Selecting a Homogeneous Population of iPSC-Derived Hepatocytes.

Authors:  Sunil K Mallanna; Max A Cayo; Kirk Twaroski; Rebekah L Gundry; Stephen A Duncan
Journal:  Stem Cell Reports       Date:  2016-08-25       Impact factor: 7.765

View more
  5 in total

1.  Functional Genomics and CRISPR Applied to Cardiovascular Research and Medicine.

Authors:  Fang Li; Jianting Shi; Hong S Lu; Hanrui Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-21       Impact factor: 8.311

2.  Doxycycline Significantly Enhances Induction of Induced Pluripotent Stem Cells to Endoderm by Enhancing Survival Through Protein Kinase B Phosphorylation.

Authors:  Caitlin Peaslee; Cristina Esteva-Font; Tao Su; Antonio Munoz-Howell; Caroline C Duwaerts; Zhe Liu; Sneha Rao; Ke Liu; Marisa Medina; Julie B Sneddon; Jacquelyn J Maher; Aras N Mattis
Journal:  Hepatology       Date:  2021-10       Impact factor: 17.298

Review 3.  Modeling Alzheimer's disease with iPSC-derived brain cells.

Authors:  Jay Penney; William T Ralvenius; Li-Huei Tsai
Journal:  Mol Psychiatry       Date:  2019-08-07       Impact factor: 15.992

4.  Generation of isogenic Propionyl-CoA carboxylase beta subunit (PCCB) deficient induced pluripotent stem cell lines.

Authors:  Behshad Pournasr; Stephen A Duncan
Journal:  Stem Cell Res       Date:  2020-08-08       Impact factor: 2.020

Review 5.  Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview.

Authors:  Sandra Torres; Zeinab Abdullah; Maximilian J Brol; Claus Hellerbrand; Mercedes Fernandez; Romina Fiorotto; Sabine Klein; Philipp Königshofer; Christian Liedtke; Sophie Lotersztajn; Yulia A Nevzorova; Robert Schierwagen; Thomas Reiberger; Frank Erhard Uschner; Frank Tacke; Ralf Weiskirchen; Jonel Trebicka
Journal:  Int J Mol Sci       Date:  2020-03-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.